Endo Pharmaceuticals Holdings Inc., of Chadds Ford, said second-quarter profit rose 6 percent, to $54.6 million, or 44 cents per share, for the drug and medical device maker.
Philly.com Business, Philadelphia Inquirer & Daily News: Business
Tue, 08/09/2011 - 10:44am
Endo Pharmaceuticals Holdings Inc., of Chadds Ford, said second-quarter profit rose 6 percent, to $54.6 million, or 44 cents per share, for the drug and medical device maker.